We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

WuXi AppTec Completes Acquisition of OXGENE To Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers

Product News   Mar 05, 2021

 
WuXi AppTec Completes Acquisition of OXGENE To Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Adaptate Biotherapeutics Raises $18 million in Series A2 Funding

Product News

Adaptate Biotherapeutics has announced that its existing investors, Abingworth and Takeda Pharmaceutical Company Limited have together made a further equity investment of $18 million.

READ MORE

Phico Therapeutics Awarded Funding To Advance SASPject Antibacterial Therapy Through Phase 1 Clinical Trials

Product News

Phico Therapeutics Ltd has been awarded a grant of up to $18.2 million USD from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). The funding will support the progression of Phico’s lead product SASPject™ PT3.9 through clinical trials.

READ MORE

Eppendorf Introduces Multipurpose Centrifuge 5910 Ri To Accelerate Results

Product News

Eppendorf has introduced a new centrifuge designed to increase efficiency in the laboratory, Centrifuge 5910 Ri.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE